STRATA Skin Sciences Cash Flow - Annual (NASDAQ:SSKN)

Add to My Stocks
$3.45 $0.02 (0.58%) SSKN stock closing price Sep 19, 2018 (Closing)

The financial analysis of SSKN requires an investor to check the cash flows for STRATA Skin Sciences. Financials statements like the STRATA Skin Sciences income statement and STRATA Skin Sciences balance sheet show that the company has profits and debt, while the cash flow statement provides details of cash flow movments. The cash flow statement is essetial while conducting the STRATA Skin Sciences cash flow analysis and can be used to measure the operating performance of STRATA Skin Sciences compared to various industry peers like NH stock and POTN stock. STRATA Skin Sciences saw a outflow of $-2.19M from investing activities for 2017.

View details of STRATA Skin Sciences cash flows for latest & last 10 financial years
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow8.88M9.03M12.92M3.92M2.68M2.45M-1.28M1.14M1.17M
Net Increase (Decrease) in Assets Liabilities1.36M-0.58M-0.37M-0.91M-0.15M--0.99M-0.16M-0.01M-
Cash From (used in) Discontinued Operations----------
Other Adjustments Net12.72M-4.79M5.81M-6.57M4M-3.35M-0.01M--
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.32M--0.03M--5.18M-6.15M-0.1M-1.03M-1.25M-0.31M
Acquisition Disposition of Subsidiaires---42.5M-------
Increase (Decrease) in Investments---------1.33M
Other Cash Inflow (Outflow) from Investment Activities-1.87M-0.99M-1.68M-------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares---11.35M21.19M5.24M15.03M20.7M34.25M11.99M
Issuance (Repayment) of Debt Securities-1.42M1.5M42.89M13.98M-0.67M-----
Increase (Decrease) in Bank & Other Borrowings-0.37M-0.33M-0.09M-------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities---0.13M------1.49M-0.93M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year3.92M3.3M11.43M3.78M7.86M27.99M30.52M29.67M15.06M19.19M
Cash & Equivalents at Year End4.06M3.92M3.3M11.43M3.78M7.86M27.99M30.52M29.67M15.06M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

STRATA Skin Sciences stock price history provides insight into historical stock price fluctuations, and STRATA Skin Sciences stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that STRATA Skin Sciences is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - STRATA Skin Sciences stock price movement.
  • The cash generated from the core business or operations was a positive at $4.14M for STRATA Skin Sciences in the latest 2017. For an internet company, this would include all those activities which are involved in eventually selling advertisement space on its website or any online service.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $-2.19M for SSKN stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. STRATA Skin Sciences spent $-1.8M from financing activities, in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For STRATA Skin Sciences Cash Flow

Annual Cash Flow Statements For STRATA Skin Sciences Inc Peers

Cutera cash flow, MiMedx cash flow, NantHealth cash flow, Sientra cash flow